This document outlines the agenda and speakers for a conference on best clinical practices for using low molecular weight heparin (LMWH). The one-day conference is divided into 5 modules covering topics like managing venous thromboembolism (VTE) treatment and duration, using LMWH for cancer patients and during pregnancy, and surgical thromboprophylaxis. Each module includes workshops presenting clinical cases and discussions. There are also speaker corners for informal discussions with conference speakers. The goal is to review different clinical approaches and reach consensus on key aspects of LMWH use.